Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer.
Saved in:
| Title: | Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. |
|---|---|
| Authors: | Tournier B; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Pathology, Dijon University Hospital, 21000 Dijon, France., Aucagne R; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France., Truntzer C; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Centre Georges-François Leclerc (CGFL), 21000 Dijon, France., Fournier C; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France., Ghiringhelli F; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France.; Centre Georges-François Leclerc (CGFL), 21000 Dijon, France., Chapusot C; Department of Pathology, Dijon University Hospital, 21000 Dijon, France., Martin L; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Pathology, Dijon University Hospital, 21000 Dijon, France., Bouvier AM; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France., Manfredi S; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France., Jooste V; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France., Callanan MB; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France., Lepage C; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France. |
| Source: | Cancers [Cancers (Basel)] 2022 Dec 27; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36612154 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tournier+B%22">Tournier B</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Pathology, Dijon University Hospital, 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Aucagne+R%22">Aucagne R</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Truntzer+C%22">Truntzer C</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Centre Georges-François Leclerc (CGFL), 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Fournier+C%22">Fournier C</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Ghiringhelli+F%22">Ghiringhelli F</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France.; Centre Georges-François Leclerc (CGFL), 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Chapusot+C%22">Chapusot C</searchLink>; Department of Pathology, Dijon University Hospital, 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Martin+L%22">Martin L</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Pathology, Dijon University Hospital, 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Bouvier+AM%22">Bouvier AM</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Manfredi+S%22">Manfredi S</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Jooste+V%22">Jooste V</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Callanan+MB%22">Callanan MB</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Unit for Innovation in Genetics and Epigenetics in Oncology (IGEO) and CRIGEN (Crispr Functional Genomics), Dijon University Hospital, 21000 Dijon, France.; Genetics and Immunology Medical Institute (GIMI), 21000 Dijon, France.<br /><searchLink fieldCode="AU" term="%22Lepage+C%22">Lepage C</searchLink>; Faculty of Health Sciences, University of Burgundy, 21000 Dijon, France.; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR1231, 21000 Dijon, France.; Department of Hepato-Gastroenterology and Digestive Oncology, Dijon University Hospital, 21000 Dijon, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2022 Dec 27; Vol. 15 (1). <i>Date of Electronic Publication: </i>2022 Dec 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36612154 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers15010158 Languages: – Code: eng Text: English Titles: – TitleFull: Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tournier B – PersonEntity: Name: NameFull: Aucagne R – PersonEntity: Name: NameFull: Truntzer C – PersonEntity: Name: NameFull: Fournier C – PersonEntity: Name: NameFull: Ghiringhelli F – PersonEntity: Name: NameFull: Chapusot C – PersonEntity: Name: NameFull: Martin L – PersonEntity: Name: NameFull: Bouvier AM – PersonEntity: Name: NameFull: Manfredi S – PersonEntity: Name: NameFull: Jooste V – PersonEntity: Name: NameFull: Callanan MB – PersonEntity: Name: NameFull: Lepage C IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 12 Text: 2022 Dec 27 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 2072-6694 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: Cancers Type: main |
| ResultId | 1 |